A raw material may meet its written specifications and still introduce unexpected risk once it enters a sensitive manufacturing process. Small differences in purity, storage, sourcing, or lot performance can affect consistency, quality, and supply continuity.  

That is why a biomanufacturing reagent risk register is more than a routine record. It helps teams identify concerns early, score them consistently, assign clear ownership, and track mitigation before problems reach production.  

But what should the register include, and how should each risk be prioritized? This guide breaks down the essential fields, scoring method, controls, and review steps needed for a practical raw material assessment. 

Key Takeaways 

Core Fields in a Biomanufacturing Reagent Risk Register 

A practical risk register should identify the material, define its process role, document potential hazards, and record the controls used to manage them. This structure helps quality, procurement, manufacturing, and laboratory teams evaluate materials consistently throughout their lifecycle. 

Record Material Identification 

Each biomanufacturing reagent entry should include: 

A typical tiering model may include: 

Organizations should adapt these definitions to their processes, material criticality criteria, intended applications, and quality systems. The assigned tier can then guide the appropriate level of qualification, testing, supplier oversight, and review frequency. 

A material purchased through a general lab reagent store may require additional qualification if its manufacturing controls, intended use, or supporting documentation do not meet bioprocessing requirements. 

Describe Relevant Hazards 

The hazard description should identify what could go wrong and explain its potential process impact. Risks can be grouped into four categories. 

Biological Hazards 

Chemical Hazards 

Chemical concerns may include impurities, residual solvents, elemental contaminants, concentration variability, or unexpected interactions. 

Physical Hazards 

Physical risks may include damaged packaging, particulate matter, compromised containers, or unsuitable storage conditions. 

Supply Hazards 

Supply risks may involve sole-source dependency, extended lead times, limited capacity, geographic disruption, or inadequate change notifications. Even technically suitable lab reagents may create manufacturing difficulties when traceability or availability is unreliable. 

Evaluate and Score Material Risk 

A standardized scoring system allows different departments to evaluate materials using the same criteria. Each biomanufacturing reagent should be assessed according to severity, occurrence, and detectability. 

Assign the Severity Score 

Severity measures the possible effect of a hazard. A score of 1 may represent minimal impact, while a score of 5 may indicate serious consequences for product quality, patient safety, compliance, or manufacturing continuity. 

Materials used in direct-contact or essential biological stages may receive higher scores because failures can be difficult to correct after processing begins. 

Measure Occurrence 

Occurrence reflects how likely the event is to happen. Reviewers may consider: 

Stable performance and limited quality issues may support a low score. Variable composition, repeated failures, or insufficient historical evidence may justify a higher score. 

Assess Detectability 

Detectability measures how likely the issue is to be discovered before the material affects production. A low score may apply when routine checks reliably reveal the problem. A higher score may be appropriate when variability becomes visible only during later stages. 

In this model, a higher detectability score means the problem is harder to detect before use. 

This consideration is particularly important for serum-free media, where standard identity tests may not reveal meaningful functional differences between lots. 

The Risk Priority Number is calculated as: 

RPN = Severity × Occurrence × Detectability 

For example: 

5 × 3 × 4 = 60 

Organizations should define their own thresholds for low, moderate, and high risk. The RPN supports prioritization but should not replace scientific judgment, especially when a hazard has high severity. 

Biomanufacturing Reagent Mitigation and Control Strategies 

Once risks have been scored, the register should separate established controls from new measures needed to address unresolved concerns. 

Document Existing Controls 

Current controls may include: 

Each control should identify its method, frequency, responsible function, and supporting record. Statements such as “supplier approved” should be replaced with specific audit dates, approval status, review scope, and relevant records. 

A qualified reagent company should provide defined specifications, traceable documentation, formal change notifications, and responsive quality support.